Narlumosbart (JMT103)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Narlumosbart (JMT103), covering 2023-04-19 to 2023-04-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone [Phase 3]